You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 18, 2024

ACETAZOLAMIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Acetazolamide patents expire, and what generic alternatives are available?

Acetazolamide is a drug marketed by Accord Hlthcare, Alembic, Cadila, Heritage Pharma, Indicus Pharma, Micro Labs Ltd India, Nostrum Labs Inc, Novast Labs, Rising, Ajanta Pharma Ltd, Alra, Appco, Ascot, Breckenridge, Chartwell Molecular, Eywa Pharma, Mankind Pharma, Ne Rx Pharma, Novitium Pharma, Rubicon, Strides Pharma, Sun Pharm Industries, Taro, Torrent, Vangard, Watson Labs, Zydus, Avet Lifesciences, Hikma, Hospira, Mylan Asi, Par Sterile Products, Xgen Pharms, and Zydus Pharms. and is included in thirty-six NDAs.

The generic ingredient in ACETAZOLAMIDE is acetazolamide sodium. There are ten drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Acetazolamide

A generic version of ACETAZOLAMIDE was approved as acetazolamide sodium by HIKMA on February 28th, 1995.

  Try a Trial

Drug patent expirations by year for ACETAZOLAMIDE
Drug Prices for ACETAZOLAMIDE

See drug prices for ACETAZOLAMIDE

Recent Clinical Trials for ACETAZOLAMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Incannex Healthcare LtdPhase 1
Rambam Health Care CampusPhase 4
National Heart, Lung, and Blood Institute (NHLBI)Phase 2

See all ACETAZOLAMIDE clinical trials

Pharmacology for ACETAZOLAMIDE
Medical Subject Heading (MeSH) Categories for ACETAZOLAMIDE

US Patents and Regulatory Information for ACETAZOLAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs ACETAZOLAMIDE acetazolamide TABLET;ORAL 084498-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma ACETAZOLAMIDE acetazolamide TABLET;ORAL 209734-001 Nov 20, 2017 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Xgen Pharms ACETAZOLAMIDE SODIUM acetazolamide sodium INJECTABLE;INJECTION 040784-001 Dec 10, 2008 AP RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.